Shares of Septerna Inc. were soaring in early Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

HHP doctoral student Hannah Gustafson has won NASA Human Research Program's Grant Augmentation Award. The award given to students and postdocs provides $25,000 support for 1 year for two of Hannah's ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.